Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Celanese CorpCE · Entity 3922 | Director | May 09, 2025 | May 13, 2025 |
| GLAUKOS CorpGKOS · Entity 3510 | Director | May 28, 2026 | June 23, 2026 |
| ICU MEDICAL INC/DEICUI · Entity 2385 | Director | May 13, 2026 | May 14, 2026 |
| StepStone Group Inc.STEP · Entity 3755 | Director | September 08, 2026 | September 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Celanese Corp
Report date May 09, 2025 · Filed May 13, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,490 |
Reported balance
After 2025-05-09 transaction · row 1
1 source rowRow 1 · 2025-05-09 · Grant · Acquired 3,376 · Balance 4,490 F1: Annual grant of restricted stock units pursuant to the Company's Amended and Restated 2018 Global Incentive Plan. The restricted stock units vest in full on the one-year anniversary of the date of grant. |
| Common StockSEC Table I · non-derivative | IndirectBy Sentinel Point Partners, Inc. | 50,270 |
Reported balance
Holding disclosure · report date 2025-05-09 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 50,270 |
Filing footnotes · ownership attribution and instrument terms
F1: Annual grant of restricted stock units pursuant to the Company's Amended and Restated 2018 Global Incentive Plan. The restricted stock units vest in full on the one-year anniversary of the date of grant.
GLAUKOS Corp
Report date May 28, 2026 · Filed June 23, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $106.52 · Expires 2036-05-28 | Direct | 2,987 |
Reported balance
After 2026-05-28 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2026-05-28 · Grant · Acquired 2,987 · Balance 2,987 F1: This Form 4A amends a Form 4 filed June 1, 2026 that incorrectly reported the exercise price of options granted to the Reporting Person on May 28, 2026 as $53.57. The correct exercise price for the options granted is $106.52, as shown above. F2: Granted pursuant to the Issuer's Director Compensation Policy. Vests in full on the one-year anniversary of grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4A amends a Form 4 filed June 1, 2026 that incorrectly reported the exercise price of options granted to the Reporting Person on May 28, 2026 as $53.57. The correct exercise price for the options granted is $106.52, as shown above.
F2: Granted pursuant to the Issuer's Director Compensation Policy. Vests in full on the one-year anniversary of grant date.
ICU MEDICAL INC/DE
Report date May 13, 2026 · Filed May 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,004 |
Reported balance
After 2026-05-13 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-13 · Exercise / conversion · Acquired 1,254 · Balance 6,004 F1: These securities are Restricted Stock Units. |
| Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2026-05-13 | Direct | 0 |
Reported balance
After 2026-05-13 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-13 · Exercise / conversion · Disposed 1,254 · Balance 0 F1: These securities are Restricted Stock Units. F2: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first. |
| Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2027-05-13 | Direct | 1,475 |
Reported balance
After 2026-05-13 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-13 · Grant · Acquired 1,475 · Balance 1,475 F1: These securities are Restricted Stock Units. F2: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities are Restricted Stock Units.
F2: There is neither a purchase price nor an exercise price for the Restricted Stock Units.
F3: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.
StepStone Group Inc.
Report date September 08, 2026 · Filed September 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 19,550 |
Reported balance
After 2026-09-08 transaction · row 1
1 source rowRow 1 · 2026-09-08 · Grant · Acquired 5,616 · Balance 19,550 F1: Represents the number of shares of Class A Common Stock issued to the Reporting Person pursuant to an award of restricted stock units as compensation for the Reporting Person's service on the Issuer's board of directors. The award vests in full on the earlier of the first anniversary of the grant date or the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. |
| Class A Common StockSEC Table I · non-derivative | IndirectSentinel Point Partners Inc. | 39,536 |
Reported balance
Holding disclosure · report date 2026-09-08 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 39,536 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares of Class A Common Stock issued to the Reporting Person pursuant to an award of restricted stock units as compensation for the Reporting Person's service on the Issuer's board of directors. The award vests in full on the earlier of the first anniversary of the grant date or the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 08, 2026 Filed Sep 10, 2026 22:36 UTC | StepStone Group Inc. STEP · Entity 3755 | GrantClass A Common Stock | 5,616 | $50.74 | $284,955.84 |
DisclosureSEC source: 0001305975-26-000012 · wk-form4_1789079768.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,550 F1 · shares: Represents the number of shares of Class A Common Stock issued to the Reporting Person pursuant to an award of restricted stock units as compensation for the Reporting Person's service on the Issuer's board of directors. The award vests in full on the earlier of the first anniversary of the grant date or the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. F1 · price: Represents the number of shares of Class A Common Stock issued to the Reporting Person pursuant to an award of restricted stock units as compensation for the Reporting Person's service on the Issuer's board of directors. The award vests in full on the earlier of the first anniversary of the grant date or the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| May 28, 2026 Filed Jun 1, 2026 22:13 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantStock Option (Right to Buy) · Derivative | 2,987 | $0.00 Strike: $53.57 | $0.00 |
DisclosureSEC source: 0001305975-26-000008 · form4-06012026_100601.xml · derivative · entry 3 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,987 Underlying: Common Stock · 2,987 shares Expires 2036-05-28 F3 · derivative.exercise_date: Granted pursuant to the Issuer's Director Compensation Policy. Vests in full on the one-year anniversary of grant date Read SEC document |
| May 28, 2026 Filed Jun 1, 2026 22:13 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 1,878 | $0.00 | $0.00 |
DisclosureSEC source: 0001305975-26-000008 · form4-06012026_100601.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,549 F1 · shares: Represents a grant of restricted stock units received by the Reporting Person pursuant to the Issuer's Director Compensation Policy. The units will vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. F2 · balance_after: Includes 4,739 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person. Read SEC document |
| May 28, 2026 Filed Jun 23, 2026 23:22 UTC Amendment | GLAUKOS Corp GKOS · Entity 3510 | GrantStock Option (Right to Buy) · Derivative | 2,987 | $0.00 Strike: $106.52 | $0.00 |
DisclosureSEC source: 0001305975-26-000010 · form4a-06232026_110652.xml · derivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,987 Underlying: Common Stock · 2,987 shares Expires 2036-05-28 F1 · derivative.exercise_price: This Form 4A amends a Form 4 filed June 1, 2026 that incorrectly reported the exercise price of options granted to the Reporting Person on May 28, 2026 as $53.57. The correct exercise price for the options granted is $106.52, as shown above. F2 · derivative.exercise_date: Granted pursuant to the Issuer's Director Compensation Policy. Vests in full on the one-year anniversary of grant date. Read SEC document |
| May 26, 2026 Filed May 28, 2026 20:31 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $24.69 Strike: $24.69 | $370,350.00 |
DisclosureSEC source: 0001305975-26-000006 · form4-05282026_080506.xml · derivative · entry 3 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2026-06-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted on June 2, 2016 and fully vested on the first anniversary of the grant date. Read SEC document |
| May 26, 2026 Filed May 28, 2026 20:31 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 15,000 | $24.69 | $370,350.00 |
DisclosureSEC source: 0001305975-26-000006 · form4-05282026_080506.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,671 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 2,861 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person. Read SEC document |
| May 13, 2026 Filed May 14, 2026 00:38 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantCommon Stock · Derivative | 1,475 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001305975-26-000004 · edgardoc.xml · derivative · entry 3 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,475 Underlying: Common Stock · 1,475 shares Expires 2027-05-13 F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 13, 2026 Filed May 14, 2026 00:38 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 1,254 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001305975-26-000004 · edgardoc.xml · derivative · entry 2 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,254 shares Expires 2026-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 13, 2026 Filed May 14, 2026 00:38 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 1,254 | $0.00 | $0.00 |
DisclosureSEC source: 0001305975-26-000004 · edgardoc.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,004 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| January 02, 2026 Filed Jan 8, 2026 00:43 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 753 | $0.00 | $0.00 |
DisclosureSEC source: 0001305975-26-000002 · form4-01082026_120120.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,671 F1 · shares: Represents a grant of restricted stock units received by the Reporting Person pursuant to the Issuer's Director Compensation Policy. The units will vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. F2 · balance_after: Includes 2,861 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person. Read SEC document |
| September 09, 2025 Filed Sep 10, 2025 22:13 UTC | StepStone Group Inc. STEP · Entity 3755 | GrantClass A Common Stock | 3,691 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001305975-25-000004 · wk-form4_1757542412.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,934 F1 · shares: Represents the number of shares of Class A Common Stock issued to the Reporting Person pursuant to an award of restricted stock units as compensation for the Reporting Person's service on the Issuer's board of directors. The award vests in full on the earlier of the first anniversary of the grant date or the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. F1 · price: Represents the number of shares of Class A Common Stock issued to the Reporting Person pursuant to an award of restricted stock units as compensation for the Reporting Person's service on the Issuer's board of directors. The award vests in full on the earlier of the first anniversary of the grant date or the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 23:43 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $32.00 | $0.00 |
DisclosureSEC source: 0001415889-25-017333 · form4-06132025_110637.xml · derivative · entry 3 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2025-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Granted July 23, 2015. Vested 1/3 annually over a three-year period such that it vested in full on the three-year anniversary of the grant date. Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 23:43 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 25,000 | $32.00 | $800,000.00 |
DisclosureSEC source: 0001415889-25-017333 · form4-06132025_110637.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,918 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 2,665 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person, and reflects a transfer of 3,230 shares from the Reporting Person's direct ownership to a corporation of which the Reporting Person is the sole stockholder, thereby resulting in no change in the Reporting Person's beneficial ownership. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:43 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantStock Option (Right to Buy) · Derivative | 3,149 | $94.87 Strike: $94.87 | $298,745.63 |
DisclosureSEC source: 0001415889-25-015175 · form4-06022025_080622.xml · derivative · entry 3 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,149 Underlying: Common Stock · 3,149 shares Expires 2035-05-29 F5 · derivative.exercise_date: Granted pursuant to the Issuer's Director Compensation Policy. Vests in full on the one-year anniversary of grant date. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:43 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 2,108 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-015175 · form4-06022025_080622.xml · nonDerivative · entry 2 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,918 F3 · security: Represents a grant of restricted stock units received by the Reporting Person pursuant to the Issuer's Director Compensation Policy. The units will vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. F4 · balance_after: Includes 4,381 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person. Read SEC document |
| May 13, 2025 Filed May 14, 2025 00:03 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 1,723 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-070754 · ownership.xml · derivative · entry 3 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,723 shares Expires 2025-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 13, 2025 Filed May 14, 2025 00:03 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantCommon Stock · Derivative | 1,254 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-070754 · ownership.xml · derivative · entry 2 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,254 Underlying: Common Stock · 1,254 shares Expires 2026-05-13 F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These options vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 13, 2025 Filed May 14, 2025 00:03 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 1,723 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-070754 · ownership.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. Read SEC document |
| May 09, 2025 Filed May 13, 2025 20:18 UTC | Celanese Corp CE · Entity 3922 | GrantCommon Stock | 3,376 | $0.00 | $0.00 |
DisclosureSEC source: 0001306830-25-000115 · wk-form4_1747167494.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,490 F1 · shares: Annual grant of restricted stock units pursuant to the Company's Amended and Restated 2018 Global Incentive Plan. The restricted stock units vest in full on the one-year anniversary of the date of grant. Read SEC document |
| January 02, 2025 Filed Jun 2, 2025 20:43 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 557 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-015175 · form4-06022025_080622.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,810 F1 · shares: Represents a grant of restricted stock units received by the Reporting Person in lieu of annual director retainer fees pursuant to a stock-for-fees election under the Issuer's Director Compensation Policy. The units will vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. F2 · balance_after: Includes 3,355 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person, and reflects a transfer of 3,230 shares from the Reporting Person's direct ownership to a corporation of which the Reporting Person is the sole stockholder, thereby resulting in no change in the Reporting Person's beneficial ownership. Read SEC document |
| September 10, 2024 Filed Sep 11, 2024 20:55 UTC | StepStone Group Inc. STEP · Entity 3755 | GrantClass A Common Stock | 3,926 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001796022-24-000068 · wk-form4_1726088144.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,243 F1 · shares: Represents the number of shares of Class A Common Stock issued to the Reporting Person pursuant to an award of restricted stock units as compensation for the Reporting Person's service on the Issuer's board of directors. The award vests in full on the earlier of the first anniversary of the grant date or the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. F1 · price: Represents the number of shares of Class A Common Stock issued to the Reporting Person pursuant to an award of restricted stock units as compensation for the Reporting Person's service on the Issuer's board of directors. The award vests in full on the earlier of the first anniversary of the grant date or the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| May 30, 2024 Filed May 31, 2024 21:52 UTC | StepStone Group Inc. STEP · Entity 3755 | PurchaseClass A Common Stock | 22,500 | $44.29 | $996,525.00 |
DisclosureSEC source: 0001796022-24-000043 · wk-form4_1717192328.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,853 F1 · price: The sales reported in this Form 4 were effected in multiple trades at prices ranging from $43.86 to $44.51. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 30, 2024 Filed Jun 4, 2024 00:54 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantStock Option (Right to Buy) · Derivative | 1,246 | $0.00 Strike: $110.70 | $0.00 |
DisclosureSEC source: 0001415889-24-015232 · form4-06042024_120625.xml · derivative · entry 3 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,246 Underlying: Common Stock · 1,246 shares Expires 2034-05-30 F3 · derivative.exercise_date: Granted pursuant to the Issuer's Director Compensation Policy. Vests in full on the one-year anniversary of grant date. Read SEC document |
| May 30, 2024 Filed Jun 4, 2024 00:54 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 1,716 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-015232 · form4-06042024_120625.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,483 F1 · security: Represents a grant of restricted stock units received by the Reporting Person pursuant to the Issuer's Director Compensation Policy. The units will vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. F2 · balance_after: Includes 6,028 restricted stock units that have not yet vested or delivery of which has been deferred by the Reporting Person, and reflects a transfer of 10,000 shares from the Reporting Person's direct ownership to a corporation of which the Reporting Person is the sole stockholder, thereby resulting in no change in the Reporting Person's beneficial ownership. Read SEC document |
| May 15, 2024 Filed May 15, 2024 22:17 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 948 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-060659 · ownership.xml · derivative · entry 3 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 948 shares Expires 2024-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 15, 2024 Filed May 15, 2024 22:17 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantCommon Stock · Derivative | 1,723 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-060659 · ownership.xml · derivative · entry 2 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,723 shares Expires 2025-05-15 F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 15, 2024 Filed May 15, 2024 22:17 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 948 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-060659 · ownership.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,027 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. Read SEC document |
| May 15, 2024 Filed May 17, 2024 20:35 UTC | Celanese Corp CE · Entity 3922 | GrantCommon Stock | 1,114 | $156.96 | $174,853.44 |
DisclosureSEC source: 0001306830-24-000133 · wk-form4_1715978103.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,114 F1 · shares: Annual grant of restricted stock units pursuant to the Company's Amended and Restated 2018 Global Incentive Plan. The restricted stock units vest in full on the one-year anniversary of the date of grant. F2 · balance_after: Reflects a transfer of 50,270 shares from the Reporting Person's direct ownership to a corporation of which the Reporting Person is the sole stockholder, thereby resulting in no change in the Reporting Person's beneficial ownership. Read SEC document |
| April 10, 2024 Filed Apr 12, 2024 23:49 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $7.28 | $0.00 |
DisclosureSEC source: 0001415889-24-010785 · form4-04122024_110444.xml · derivative · entry 3 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2024-07-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Granted July 10, 2014. Vested 1/3 annually over a three-year period such that it vested in full on the three-year anniversary of the grant date. Read SEC document |
| April 10, 2024 Filed Apr 12, 2024 23:49 UTC | GLAUKOS Corp GKOS · Entity 3510 | Exercise / conversionCommon Stock | 10,000 | $7.28 | $72,750.00 |
DisclosureSEC source: 0001415889-24-010785 · form4-04122024_110444.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,767 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 4,312 restricted stock units that have not vested or been delivered to the Reporting Person, and reflects a transfer of 1,572 shares from the Reporting Person's direct ownership to a corporation of which the Reporting Person is the sole stockholder, thereby resulting in no change in the Reporting Person's beneficial ownership. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:36 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 1,082 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-000620 · form4-01042024_090156.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,399 F1 · security: Represents a grant of restricted stock units received by the Reporting Person in lieu of annual director retainer fees pursuant to a stock-for-fees election under the Issuer's Director Compensation Policy. The units will vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. F2 · balance_after: Includes 5,767 restricted stock units that have not yet vested or delivery of which has been deferred by the Reporting Person, and reflects a transfer of 23,374 shares from the Reporting Person's direct ownership to a corporation of which the Reporting Person is the sole stockholder, thereby resulting in no change in the Reporting Person's beneficial ownership. Read SEC document |
| September 13, 2023 Filed Sep 14, 2023 22:22 UTC | StepStone Group Inc. STEP · Entity 3755 | GrantClass A Common Stock | 6,317 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001796022-23-000065 · wk-form4_1694730111.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,353 F1 · shares: Represents the number of shares of Class A Common Stock issued to the Reporting Person pursuant to an award of restricted stock units as compensation for the Reporting Person's service on the Issuer's board of directors. The award vests in full on the earlier of the first anniversary of the grant date or the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. F1 · price: Represents the number of shares of Class A Common Stock issued to the Reporting Person pursuant to an award of restricted stock units as compensation for the Reporting Person's service on the Issuer's board of directors. The award vests in full on the earlier of the first anniversary of the grant date or the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 01, 2023 Filed Jun 6, 2023 00:10 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 3,230 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-009291 · form4-06062023_120648.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,631 F1 · security: Represents a grant of restricted stock units that vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. F2 · balance_after: Includes 10,621 restricted stock units that have not yet vested or have not been delivered to the Reporting Person. Read SEC document |
| May 17, 2023 Filed May 18, 2023 16:46 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantCommon Stock · Derivative | 948 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-030520 · doc4.xml · derivative · entry 3 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 948 Underlying: Common Stock · 948 shares Expires 2024-05-17 F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 17, 2023 Filed May 18, 2023 16:46 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 485 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-030520 · doc4.xml · derivative · entry 2 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 485 shares Expires 2023-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 17, 2023 Filed May 18, 2023 16:46 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 485 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-030520 · doc4.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,079 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. Read SEC document |
| May 12, 2023 Filed May 16, 2023 20:32 UTC | Celanese Corp CE · Entity 3922 | GrantCommon Stock | 1,777 | $98.46 | $174,963.42 |
DisclosureSEC source: 0001306830-23-000106 · wf-form4_168426914725786.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,270 F1 · shares: Annual grant of restricted stock units pursuant to the Company's Amended and Restated 2018 Global Incentive Plan. The restricted stock units vest in full on the one-year anniversary of the date of grant. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 23:13 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 1,572 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-000434 · form4-01042023_110142.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,401 F1 · security: Represents a grant of restricted stock units received by the Reporting Person in lieu of annual director retainer fees pursuant to a stock-for-fees election under the Issuer's Director Compensation Policy. The units will vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. F2 · balance_after: Includes 5,936 restricted stock units that have not vested or been delivered to the Reporting Person. Read SEC document |
| September 14, 2022 Filed Sep 15, 2022 23:09 UTC | StepStone Group Inc. STEP · Entity 3755 | GrantClass A Common Stock | 6,053 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001796022-22-000047 · wf-form4_166328333478199.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,036 F1 · shares: Represents the number of shares of Class A Common Stock issued to the Reporting Person pursuant to an award of restricted stock units as compensation for the Reporting Person's service on the Issuer's board of directors. The award vests in full on the earlier of the first anniversary of the grant date or the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. F1 · price: Represents the number of shares of Class A Common Stock issued to the Reporting Person pursuant to an award of restricted stock units as compensation for the Reporting Person's service on the Issuer's board of directors. The award vests in full on the earlier of the first anniversary of the grant date or the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 23:53 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 4,364 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-068665 · tm2217841-3_4seq1.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,829 F1 · security: Represents a grant of restricted stock units that vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. F2 · balance_after: Includes 8,201 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| May 17, 2022 Filed May 18, 2022 16:20 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantNon-Quakified Stock Option (right to buy) · Derivative | 1,270 | $0.00 Strike: $185.79 | $0.00 |
DisclosureSEC source: 0001209191-22-029949 · doc4.xml · derivative · entry 2 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,270 Underlying: Common Stock · 1,270 shares Expires 2033-05-17 F4 · derivative.exercise_date: These options vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 17, 2022 Filed May 18, 2022 16:20 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantCommon Stock · Derivative | 485 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-029949 · doc4.xml · derivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 485 Underlying: Common Stock · 485 shares Expires 2023-05-17 F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 11, 2022 Filed May 12, 2022 19:07 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 433 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-028500 · doc4.xml · derivative · entry 2 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 433 shares Expires 2022-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 11, 2022 Filed May 12, 2022 19:07 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 433 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-028500 · doc4.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,594 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. Read SEC document |
| May 03, 2022 Filed May 5, 2022 20:47 UTC | Celanese Corp CE · Entity 3922 | GrantCommon Stock | 1,098 | $145.68 | $159,956.64 |
DisclosureSEC source: 0001306830-22-000110 · wf-form4_165178363111091.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,493 F1 · shares: Annual grant of restricted stock units pursuant to the Company's 2018 Global Incentive Plan. The restricted stock units vest in full on the one-year anniversary of the date of grant. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 01:56 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 1,455 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-001662 · tm221974-2_4seq1.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,465 F1 · security: Represents a grant of restricted stock units received by the reporting person in lieu of annual director retainer fees pursuant to a stock-for-fees election under the Issuer's Director Compensation Policy. The units will vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. F2 · balance_after: Includes 3,837 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| September 24, 2021 Filed Sep 27, 2021 23:31 UTC | StepStone Group Inc. STEP · Entity 3755 | GrantClass A Common Stock | 3,205 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001796022-21-000057 · wf-form4_163278549846152.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,983 F1 · shares: Represents the number of shares of Class A Common Stock issued to the Reporting Person pursuant to an award of restricted stock units as compensation for the Reporting Person's service on the Issuer's board of directors. The award vests in full on the earlier of the first anniversary of the grant date or the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. F1 · price: Represents the number of shares of Class A Common Stock issued to the Reporting Person pursuant to an award of restricted stock units as compensation for the Reporting Person's service on the Issuer's board of directors. The award vests in full on the earlier of the first anniversary of the grant date or the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 22:49 UTC | GLAUKOS Corp GKOS · Entity 3510 | GrantCommon Stock | 2,382 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-077832 · tm2119039-1_4seq1.xml · nonDerivative · entry 1 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,010 F1 · security: Granted by the Issuer in the form of restricted stock units that vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. F2 · balance_after: Includes 3,362 restricted stock units that have not yet vested or been delivered to the Reporting Person. Read SEC document |
| May 11, 2021 Filed May 12, 2021 18:55 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantNon-Qualified Stock Options (right to buy) · Derivative | 1,295 | $0.00 Strike: $196.57 | $0.00 |
DisclosureSEC source: 0001209191-21-032003 · doc4.xml · derivative · entry 4 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,295 Underlying: Common Stock · 1,295 shares Expires 2032-05-11 F4 · derivative.exercise_date: These options vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first. Read SEC document |
| May 11, 2021 Filed May 12, 2021 18:55 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantCommon Stock · Derivative | 433 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-032003 · doc4.xml · derivative · entry 3 Hoffmeister David F · CIK 0001305975 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 433 Underlying: Common Stock · 433 shares Expires 2022-05-11 F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: These Restricted Stock Units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.